Price target
14.330.00 0.00%
The 6 analysts offering 1 year price forecasts for 1NE have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to 1NE in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1NE EPS for the last quarter is −0.41 EUR despite the estimation of −0.41 EUR. In the next quarter EPS is expected to reach −0.38 EUR. Track more of VERRICA PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter VERRICA PHARMACEUTICALS INC revenue is expected to reach 4.33 M EUR. Check out VERRICA PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, 1NE price target is 14.33 EUR with a max estimate of 20.34 EUR and a min estimate of 11.09 EUR. Check if this forecast comes true in a year, meanwhile watch VERRICA PHARMACEUTICALS INC stock price chart and keep track of the current situation with 1NE news and stock market news.
We've gathered opinions of 6 analysts rating 1NE stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.